Embolic protection: The FilterWire EZ™ Embolic Protection System

Expert Review of Medical Devices

Volumn 5, Issue 1, 2008, Pages 19-24

  Patel, Salil ^a   Hermiller, James ^b  

^a North East Florida Cardiovascular Center ^*  (United States)

^b Care Group   (United States)

Author keywords

Carotid artery stenting; Embolic protection; FilterWireEZ ; No reflow; Saphenous vein graft intervention

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTERY EMBOLISM; ARTICLE; ARTIFICIAL EMBOLISM; BIOMEDICAL TECHNOLOGY ASSESSMENT; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; CORONARY STENT; COST EFFECTIVENESS ANALYSIS; EMBOLISM; EMBOLISM PREVENTION; HUMAN; MEDICAL INSTRUMENTATION; PERCUTANEOUS CORONARY INTERVENTION; SURGICAL MORTALITY; THROMBUS; VEIN GRAFT DISEASE;

BLOOD VESSEL PROSTHESIS IMPLANTATION; CAROTID ARTERIES; CONTROLLED CLINICAL TRIALS AS TOPIC; EMBOLISM; GRAFT OCCLUSION, VASCULAR; HUMANS; SAPHENOUS VEIN; STENTS;

EID: 38049108318     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.5.1.19     Document Type: Article

References (31)

1. Baim DS. Percutaneous treatment of saphenous vein graft disease: the ongoing challenge. J. Am. Coll. Cardiol. 42, 1370-1372 (2003).
2. Hermiller JB. Vein graft intervention: role of embolic protection and drug-eluting stents. (2007) (In press).
3. Sdringola S, Assali A, Ghani M et al. Aortocoronary vein graft percutaneous intervention. Catheter. Cardiovasc. Interv. 54, 318-324 (2001).
4. Baim DS, Wahr D, George B et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aortocoronary bypass grafts. Circulation 105, 1285-1290 (2002).
5. Fitzgibbon GM, Kafka HP, Leach AJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J. Am. Coll. Cardiol. 28, 616-626 (1996).
6. Fasseas P, Orford JL, Denktas AE, Berger B. distal protection devices during percutaneous coronary and carotid interventions. Curr. Control. Trials Cardiovasc. Med. 2, 286-291 (2001).
7. Hong MK, Mehran R, Dangas G et al. Creatinine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 100, 2400-2405 (1999).
8. Resnik FS, Wainstein M, Lee MK et al. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. Am. Heart J. 145(1), 43-46 (2003).
9. Giugliano GR, Kuntz RE, Popma JJ, Cutlip DE, Baim DS. Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device. Am. J. Cardiol. 95, 173-177 (2005).
10. Lefkovits J, Holmes DR, Califf RM et al. Predictors and sequelae of distal embolization during saphenous vein graft interventions from the CAVEAT-II trial. Circulation 92, 734-740 (1995).
11. Roffi, M, Mukherjee D, Chew DP et al. Lack of benefit from intravenous of aortocoronary bypass grafts: a pooled analysis of five randomized clinical trials. Circulation 106, 3063-3067 (2002).
12. Bates ER, Babb JD, Casey DE et al. ACF/SCAI/SVMB/SIR/ASITN 2007 Clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents. J. Am. Coll. Cardiol. 49, 126-170 (2007).
13. Al Mubarak N, Rcubin GS, Vitek JJ, Iyer SS. Microembolization during carotid stenting with the distal-balloon antiemboli system. Int. Angiol. 21, 344-348 (2002).
14. Al-Mubarak N, Roubin GS, Vitek JJ, Iyer SS, New G, Leon MB. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation 104, 1999-2001 (2001).
15. Jordan WD Jr, Woellinger DC, Doblar DD, Plyushcheva NP, Fisher WS, McDowell HA. Microemboli detected by transcranial doppler monitor in patients during carotid angioplasty versus carotid endarterectomy. Cardiovasc. Surg. 7, 33-38 (1999).
16. Theron J, Courtheoux P, Alachkar F, Bouvard G, Maiza D. New triple coaxial catheter system for carotid angioplasty with cerebral protection. Am. J. Neuroradiol. 11, 869-874 (1990).
17. Reimers B, Schluter M, Castriota F et al. Routine use of cerebral protection during carotid artery stenting: results of a multicenter registry of 753 patients. Am. J. Med. 116, 217-222 (2004).
18. Wholey MH, Al Mubarak n, Wholey MH. Updated review of the global carotid artery stent registry. Catheter. Cardiovasc. Interv. 60, 259-266 (2003).
19. Naylor AR, Bolia A, Abbott RJ et al. Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J. Vasc. Surg. 28, 326-334 (1998).
20. Gray WA, White HF Jr, Barrett DM et al. Carotid stenting and endarterectomy: a clinical and cost comparison of revascularization strategies. Stroke 33, 1063-1070 (2002).
21. Qureshi AI, Knape C, Maroney J et al. Multicenter clinical trial of the NexStent coiled sheet stent in the treatment of extracranial carotid artery stenosis: immediate results and late clinical outcomes. J. Neurosurg. 99, 264-270 (2003)
22. Levy EI, Ecker RD, Thompson JJ et al. Toward clinical equipoise: the current case for carotid angioplasty and stent placement. Neurosurg. Focus 18, 1-8 (2005).
23. Stone GW, Rogers C, Hermiller J et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 108, 548-553 (2003).
24. Gorog DA, Foale RA, Malik I. Distal myocardial protection during percutaneous coronary intervention - when and where? J. Am. Coll. Cardiol. 46(8), 1434-1435 (2005).
25. Kundadian B, Duning J, Vijayalakshmi K, Thornley, de Bedler MA. Meta-analysis of randomized trials comparing anti-embolic devices with standard PCI for improving myocardial reperfusion in patients with acute myocardial infarction. Catheter. Cardiovasc. Interv. 6, 488-496 (2007).
26. White CJ, Iyer SS, Hopkins LN, Katzen BT, Russel ME. Carotid stenting with distal protection in high surgical risk patients: The BEACH Trial 30 Day Results. Catheter. Cardiovasc. Interv. 67, 503-512 (2006).
27. Senter SR, Nathan S, Gupta A, Klein LW. Clinical and economic outcomes of embolic protection during percutaneous coronary intervention in saphenous vein grafts. J. Invasive. Cardiol. 18, 49-53 (2006).
28. Lavelle TA, Coolong A, Kuntz KM et al. The effect of risk stratification on the cost-effectiveness of embolic protection for patients undergoing percutaneous coronary intervention of a saphenous vein graft. Presented at: The 28th Annual Meeting of the Society for Medical Decision Making. Boston, MA, USA, 15-18 October 2006.
29. Cohen DJ, Murphy SA, Maim DS et al. Cost-effiectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. J. Am. Coll. Gardiol. 44(9), 1801-1808 (2004).
30. Smith SC, Hirshfeld JW, Jacobs AK et al. ACC/AHA/SCAI 2005 guideline update for PCI (update of the 2001 PCI guidelines). J. Am. Coll. Cardiol. 47, 216-235 (2006).
31. Yadav JS, Wholey MH, Kuntz RE et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N. Engl. J. Med. 351(15), 1493-1501 (2004).